Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients

Background Dark chocolate may have blood pressure-lowering properties. We conducted a prospective randomized open-label blinded end-point design trial to study a potential dose dependency of the presumed antihypertensive effect of dark chocolate by directly comparing low vs. higher doses of dark cho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hypertension 2010-06, Vol.23 (6), p.694-700
Hauptverfasser: Desch, Steffen, Kobler, Daniela, Schmidt, Johanna, Sonnabend, Melanie, Adams, Volker, Sareban, Mahdi, Eitel, Ingo, Blüher, Matthias, Schuler, Gerhard, Thiele, Holger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 700
container_issue 6
container_start_page 694
container_title American journal of hypertension
container_volume 23
creator Desch, Steffen
Kobler, Daniela
Schmidt, Johanna
Sonnabend, Melanie
Adams, Volker
Sareban, Mahdi
Eitel, Ingo
Blüher, Matthias
Schuler, Gerhard
Thiele, Holger
description Background Dark chocolate may have blood pressure-lowering properties. We conducted a prospective randomized open-label blinded end-point design trial to study a potential dose dependency of the presumed antihypertensive effect of dark chocolate by directly comparing low vs. higher doses of dark chocolate over the course of 3 months. Methods We enrolled a total of 102 patients with prehypertension/stage 1 hypertension and established cardiovascular end-organ damage or diabetes mellitus. Patients were randomly assigned to receive either 6 or 25g/day of flavanol-rich dark chocolate for 3 months. The difference in 24-h mean blood pressure between groups was defined as the primary outcome measure. Results Significant reductions in mean ambulatory 24-h blood pressure were observed between baseline and follow-up in both groups (6g/day: −2.3mmHg, 95% confidence interval −4.1 to −0.4; 25g/day: −1.9mmHg, 95% confidence interval −3.6 to −0.2). There were no significant differences in blood pressure changes between groups. In the higher-dose group, a slight increase in body weight was noted (0.8kg, 95% confidence interval 0.06 to 1.6). Conclusions The findings are consistent with the hypothesis that dark chocolate may be associated with a reduction in blood pressure (BP). However, due to the lack of a control group, confounding may be possible and the results should be interpreted with caution.
doi_str_mv 10.1038/ajh.2010.29
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733317924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1038/ajh.2010.29</oup_id><sourcerecordid>733317924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c542t-42668b5a1534e43571f045124348e3fa7aed30b9bad8957a928d42d81a100193</originalsourceid><addsrcrecordid>eNqF0c1v0zAYBnALgVgpnLiDpYlxQCn-jOMjdECRKlGVCaFerLeJQ92mcbGTMf573KVsEhdOlqWfn9d-jNBzSiaU8OItbDcTRtKO6QdoRLWgmWJMPkQjUmiZKZLTM_Qkxi0hROQ5fYzOGGGE50yN0Gruf-HrOMEz92NjQ3bpo8WXEHZ4uvGlb6CzGNoKv2-8r_Ai2Bj7YLFr8RRC5fw1xLJvINyez5Yu7vACOmfbLj5Fj2poon12Wsfo6uOHq-ksm3_59Hn6bp6VUrAuEyzPi7UEKrmwgktFayIkZYKLwvIaFNiKk7VeQ5Weo0CzohKsKihQQqjmY_R6iD0E_7O3sTN7F0vbNNBa30ejOOdU6ZQ3Ruf_yK3vQ5vuZihhQmqSa5bUm0GVwccYbG0Owe0h_E7IHAs3qXBzLNyw4_QXp8x-vbfVnf3bcAKvTiA1BU0doC1dvHesoJoomtzF4Hx_-M_ElwNsoUtfcWeTOZJbkQ3Cxc7e3IOwM7niSprZ95Why29fVwutzZL_AZeyq3o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024590692</pqid></control><display><type>article</type><title>Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Desch, Steffen ; Kobler, Daniela ; Schmidt, Johanna ; Sonnabend, Melanie ; Adams, Volker ; Sareban, Mahdi ; Eitel, Ingo ; Blüher, Matthias ; Schuler, Gerhard ; Thiele, Holger</creator><creatorcontrib>Desch, Steffen ; Kobler, Daniela ; Schmidt, Johanna ; Sonnabend, Melanie ; Adams, Volker ; Sareban, Mahdi ; Eitel, Ingo ; Blüher, Matthias ; Schuler, Gerhard ; Thiele, Holger</creatorcontrib><description>Background Dark chocolate may have blood pressure-lowering properties. We conducted a prospective randomized open-label blinded end-point design trial to study a potential dose dependency of the presumed antihypertensive effect of dark chocolate by directly comparing low vs. higher doses of dark chocolate over the course of 3 months. Methods We enrolled a total of 102 patients with prehypertension/stage 1 hypertension and established cardiovascular end-organ damage or diabetes mellitus. Patients were randomly assigned to receive either 6 or 25g/day of flavanol-rich dark chocolate for 3 months. The difference in 24-h mean blood pressure between groups was defined as the primary outcome measure. Results Significant reductions in mean ambulatory 24-h blood pressure were observed between baseline and follow-up in both groups (6g/day: −2.3mmHg, 95% confidence interval −4.1 to −0.4; 25g/day: −1.9mmHg, 95% confidence interval −3.6 to −0.2). There were no significant differences in blood pressure changes between groups. In the higher-dose group, a slight increase in body weight was noted (0.8kg, 95% confidence interval 0.06 to 1.6). Conclusions The findings are consistent with the hypothesis that dark chocolate may be associated with a reduction in blood pressure (BP). However, due to the lack of a control group, confounding may be possible and the results should be interpreted with caution.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>EISSN: 1879-1905</identifier><identifier>DOI: 10.1038/ajh.2010.29</identifier><identifier>PMID: 20203627</identifier><identifier>CODEN: AJHYE6</identifier><language>eng</language><publisher>Basingstoke: Oxford University Press</publisher><subject>Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; blood pressure ; Blood Pressure - drug effects ; Blood Pressure Monitoring, Ambulatory ; Cacao ; Candy ; Cardiology. Vascular system ; Cardiovascular Diseases - etiology ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; cocoa ; dark chocolate ; Diabetes Complications - physiopathology ; Female ; flavanols ; Humans ; hypertension ; Hypertension - complications ; Hypertension - drug therapy ; Male ; Medical sciences ; Risk</subject><ispartof>American journal of hypertension, 2010-06, Vol.23 (6), p.694-700</ispartof><rights>American Journal of Hypertension, Ltd. © 2010 by the American Journal of Hypertension, Ltd. 2010</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Jun 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c542t-42668b5a1534e43571f045124348e3fa7aed30b9bad8957a928d42d81a100193</citedby><cites>FETCH-LOGICAL-c542t-42668b5a1534e43571f045124348e3fa7aed30b9bad8957a928d42d81a100193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22819071$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20203627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Desch, Steffen</creatorcontrib><creatorcontrib>Kobler, Daniela</creatorcontrib><creatorcontrib>Schmidt, Johanna</creatorcontrib><creatorcontrib>Sonnabend, Melanie</creatorcontrib><creatorcontrib>Adams, Volker</creatorcontrib><creatorcontrib>Sareban, Mahdi</creatorcontrib><creatorcontrib>Eitel, Ingo</creatorcontrib><creatorcontrib>Blüher, Matthias</creatorcontrib><creatorcontrib>Schuler, Gerhard</creatorcontrib><creatorcontrib>Thiele, Holger</creatorcontrib><title>Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>Background Dark chocolate may have blood pressure-lowering properties. We conducted a prospective randomized open-label blinded end-point design trial to study a potential dose dependency of the presumed antihypertensive effect of dark chocolate by directly comparing low vs. higher doses of dark chocolate over the course of 3 months. Methods We enrolled a total of 102 patients with prehypertension/stage 1 hypertension and established cardiovascular end-organ damage or diabetes mellitus. Patients were randomly assigned to receive either 6 or 25g/day of flavanol-rich dark chocolate for 3 months. The difference in 24-h mean blood pressure between groups was defined as the primary outcome measure. Results Significant reductions in mean ambulatory 24-h blood pressure were observed between baseline and follow-up in both groups (6g/day: −2.3mmHg, 95% confidence interval −4.1 to −0.4; 25g/day: −1.9mmHg, 95% confidence interval −3.6 to −0.2). There were no significant differences in blood pressure changes between groups. In the higher-dose group, a slight increase in body weight was noted (0.8kg, 95% confidence interval 0.06 to 1.6). Conclusions The findings are consistent with the hypothesis that dark chocolate may be associated with a reduction in blood pressure (BP). However, due to the lack of a control group, confounding may be possible and the results should be interpreted with caution.</description><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure Monitoring, Ambulatory</subject><subject>Cacao</subject><subject>Candy</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>cocoa</subject><subject>dark chocolate</subject><subject>Diabetes Complications - physiopathology</subject><subject>Female</subject><subject>flavanols</subject><subject>Humans</subject><subject>hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Risk</subject><issn>0895-7061</issn><issn>1941-7225</issn><issn>1879-1905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqF0c1v0zAYBnALgVgpnLiDpYlxQCn-jOMjdECRKlGVCaFerLeJQ92mcbGTMf573KVsEhdOlqWfn9d-jNBzSiaU8OItbDcTRtKO6QdoRLWgmWJMPkQjUmiZKZLTM_Qkxi0hROQ5fYzOGGGE50yN0Gruf-HrOMEz92NjQ3bpo8WXEHZ4uvGlb6CzGNoKv2-8r_Ai2Bj7YLFr8RRC5fw1xLJvINyez5Yu7vACOmfbLj5Fj2poon12Wsfo6uOHq-ksm3_59Hn6bp6VUrAuEyzPi7UEKrmwgktFayIkZYKLwvIaFNiKk7VeQ5Weo0CzohKsKihQQqjmY_R6iD0E_7O3sTN7F0vbNNBa30ejOOdU6ZQ3Ruf_yK3vQ5vuZihhQmqSa5bUm0GVwccYbG0Owe0h_E7IHAs3qXBzLNyw4_QXp8x-vbfVnf3bcAKvTiA1BU0doC1dvHesoJoomtzF4Hx_-M_ElwNsoUtfcWeTOZJbkQ3Cxc7e3IOwM7niSprZ95Why29fVwutzZL_AZeyq3o</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Desch, Steffen</creator><creator>Kobler, Daniela</creator><creator>Schmidt, Johanna</creator><creator>Sonnabend, Melanie</creator><creator>Adams, Volker</creator><creator>Sareban, Mahdi</creator><creator>Eitel, Ingo</creator><creator>Blüher, Matthias</creator><creator>Schuler, Gerhard</creator><creator>Thiele, Holger</creator><general>Oxford University Press</general><general>Nature Publishing Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100601</creationdate><title>Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients</title><author>Desch, Steffen ; Kobler, Daniela ; Schmidt, Johanna ; Sonnabend, Melanie ; Adams, Volker ; Sareban, Mahdi ; Eitel, Ingo ; Blüher, Matthias ; Schuler, Gerhard ; Thiele, Holger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c542t-42668b5a1534e43571f045124348e3fa7aed30b9bad8957a928d42d81a100193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure Monitoring, Ambulatory</topic><topic>Cacao</topic><topic>Candy</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>cocoa</topic><topic>dark chocolate</topic><topic>Diabetes Complications - physiopathology</topic><topic>Female</topic><topic>flavanols</topic><topic>Humans</topic><topic>hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Risk</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desch, Steffen</creatorcontrib><creatorcontrib>Kobler, Daniela</creatorcontrib><creatorcontrib>Schmidt, Johanna</creatorcontrib><creatorcontrib>Sonnabend, Melanie</creatorcontrib><creatorcontrib>Adams, Volker</creatorcontrib><creatorcontrib>Sareban, Mahdi</creatorcontrib><creatorcontrib>Eitel, Ingo</creatorcontrib><creatorcontrib>Blüher, Matthias</creatorcontrib><creatorcontrib>Schuler, Gerhard</creatorcontrib><creatorcontrib>Thiele, Holger</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desch, Steffen</au><au>Kobler, Daniela</au><au>Schmidt, Johanna</au><au>Sonnabend, Melanie</au><au>Adams, Volker</au><au>Sareban, Mahdi</au><au>Eitel, Ingo</au><au>Blüher, Matthias</au><au>Schuler, Gerhard</au><au>Thiele, Holger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>23</volume><issue>6</issue><spage>694</spage><epage>700</epage><pages>694-700</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><eissn>1879-1905</eissn><coden>AJHYE6</coden><abstract>Background Dark chocolate may have blood pressure-lowering properties. We conducted a prospective randomized open-label blinded end-point design trial to study a potential dose dependency of the presumed antihypertensive effect of dark chocolate by directly comparing low vs. higher doses of dark chocolate over the course of 3 months. Methods We enrolled a total of 102 patients with prehypertension/stage 1 hypertension and established cardiovascular end-organ damage or diabetes mellitus. Patients were randomly assigned to receive either 6 or 25g/day of flavanol-rich dark chocolate for 3 months. The difference in 24-h mean blood pressure between groups was defined as the primary outcome measure. Results Significant reductions in mean ambulatory 24-h blood pressure were observed between baseline and follow-up in both groups (6g/day: −2.3mmHg, 95% confidence interval −4.1 to −0.4; 25g/day: −1.9mmHg, 95% confidence interval −3.6 to −0.2). There were no significant differences in blood pressure changes between groups. In the higher-dose group, a slight increase in body weight was noted (0.8kg, 95% confidence interval 0.06 to 1.6). Conclusions The findings are consistent with the hypothesis that dark chocolate may be associated with a reduction in blood pressure (BP). However, due to the lack of a control group, confounding may be possible and the results should be interpreted with caution.</abstract><cop>Basingstoke</cop><pub>Oxford University Press</pub><pmid>20203627</pmid><doi>10.1038/ajh.2010.29</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American journal of hypertension, 2010-06, Vol.23 (6), p.694-700
issn 0895-7061
1941-7225
1879-1905
language eng
recordid cdi_proquest_miscellaneous_733317924
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
blood pressure
Blood Pressure - drug effects
Blood Pressure Monitoring, Ambulatory
Cacao
Candy
Cardiology. Vascular system
Cardiovascular Diseases - etiology
Clinical manifestations. Epidemiology. Investigative techniques. Etiology
cocoa
dark chocolate
Diabetes Complications - physiopathology
Female
flavanols
Humans
hypertension
Hypertension - complications
Hypertension - drug therapy
Male
Medical sciences
Risk
title Low vs. Higher-Dose Dark Chocolate and Blood Pressure in Cardiovascular High-Risk Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T04%3A13%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20vs.%20Higher-Dose%20Dark%20Chocolate%20and%20Blood%20Pressure%20in%20Cardiovascular%20High-Risk%20Patients&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Desch,%20Steffen&rft.date=2010-06-01&rft.volume=23&rft.issue=6&rft.spage=694&rft.epage=700&rft.pages=694-700&rft.issn=0895-7061&rft.eissn=1941-7225&rft.coden=AJHYE6&rft_id=info:doi/10.1038/ajh.2010.29&rft_dat=%3Cproquest_cross%3E733317924%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1024590692&rft_id=info:pmid/20203627&rft_oup_id=10.1038/ajh.2010.29&rfr_iscdi=true